Kimberly-Clark (NYSE:KMB) Price Target Raised to $138.00

Kimberly-Clark (NYSE:KMB) had its target price upped by UBS Group from $135.00 to $138.00 in a report published on Wednesday, Benzinga reports. They currently have a neutral rating on the stock.

Several other equities research analysts have also recently issued reports on the stock. Piper Sandler boosted their price objective on shares of Kimberly-Clark from $145.00 to $152.00 and gave the company an overweight rating in a research report on Thursday, March 28th. Royal Bank of Canada reaffirmed a sector perform rating and issued a $123.00 price target on shares of Kimberly-Clark in a research report on Thursday, March 28th. Barclays boosted their price objective on shares of Kimberly-Clark from $124.00 to $132.00 and gave the stock an equal weight rating in a research note on Friday, April 12th. StockNews.com upgraded shares of Kimberly-Clark from a hold rating to a buy rating in a research note on Thursday, April 11th. Finally, Wells Fargo & Company boosted their price objective on shares of Kimberly-Clark from $131.00 to $136.00 and gave the stock an equal weight rating in a research note on Wednesday. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of Hold and an average price target of $134.85.

Kimberly-Clark Price Performance

KMB stock opened at $135.24 on Wednesday. Kimberly-Clark has a 12 month low of $116.32 and a 12 month high of $147.09. The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 6.05. The company has a 50-day moving average price of $125.86 and a 200 day moving average price of $122.87. The stock has a market cap of $45.54 billion, a PE ratio of 24.86, a P/E/G ratio of 3.90 and a beta of 0.40.

Kimberly-Clark (NYSE:KMB) last released its quarterly earnings results on Tuesday, April 23rd. The company reported $2.01 EPS for the quarter, topping analysts’ consensus estimates of $1.61 by $0.40. The firm had revenue of $5.15 billion during the quarter, compared to analysts’ expectations of $5.08 billion. Kimberly-Clark had a net margin of 9.05% and a return on equity of 250.28%. The firm’s revenue for the quarter was down .9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.67 EPS. Equities research analysts anticipate that Kimberly-Clark will post 6.98 earnings per share for the current year.

Insider Activity

In related news, insider Paula Ramos sold 10,178 shares of the stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the sale, the insider now directly owns 795 shares of the company’s stock, valued at $109,050.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Paula Ramos sold 10,178 shares of the stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the sale, the insider now directly owns 795 shares of the company’s stock, valued at $109,050.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark T. Smucker purchased 827 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were purchased at an average cost of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the acquisition, the director now directly owns 827 shares of the company’s stock, valued at approximately $100,050.46. The disclosure for this purchase can be found here. Insiders own 0.62% of the company’s stock.

Hedge Funds Weigh In On Kimberly-Clark

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. OFI Invest Asset Management purchased a new position in Kimberly-Clark during the third quarter valued at $25,000. Rise Advisors LLC raised its position in shares of Kimberly-Clark by 926.3% in the first quarter. Rise Advisors LLC now owns 195 shares of the company’s stock valued at $25,000 after buying an additional 176 shares during the last quarter. Cranbrook Wealth Management LLC raised its position in shares of Kimberly-Clark by 90.9% in the fourth quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock valued at $26,000 after buying an additional 100 shares during the last quarter. Accordant Advisory Group Inc acquired a new stake in shares of Kimberly-Clark in the first quarter valued at about $27,000. Finally, Centerpoint Advisors LLC raised its position in shares of Kimberly-Clark by 175.0% in the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock valued at $33,000 after buying an additional 175 shares during the last quarter. 76.29% of the stock is owned by hedge funds and other institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.